Trial site
Manchester
- 9running trials
- 8closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia3 trials
- Myelodysplastic syndromes3 trials
- Childhood cancers2 trials
- Coronary artery disease2 trials
- Melanoma2 trials
- Stroke2 trials
- ANCA-associated vasculitis1 trial
- Aortic stenosis1 trial
- Chronic spontaneous urticaria1 trial
- Colorectal cancer1 trial
- Huntington's disease1 trial
- Kidney cancer1 trial
- and 4 more
- Phase
- Phase 26 trials
- Phase 36 trials
- Phase 13 trials
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Completed5 trials
- Terminated3 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals16 trials
- Advanced Accelerator Applications1 trial
Running trials
Active, not recruiting
Active, not recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Active, not recruiting
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aortic stenosis1 recruiting
Closed trials
Completed
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
Terminated
Completed
Terminated
Completed
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026